Hitachi Partners with Bao Viet Insurance to Drive Innovation in Insurance Business using AI and Medical Big Data

ruth 1 10 月

6 minutes

HANOI, Vietnam, Oct 1, 2021 - (JCN Newswire via SEAPRWire.com) - Bao Viet Insurance, the largest Non-life insurance company of the Socialist Republic of Vietnam, Hitachi, Ltd., and Hitachi Asia (Vietnam) Co, Ltd., Hitachi's local subsidiary in Vietnam, have signed an agreement to collaborate and drive innovation in the insurance business. The collaboration will integrate digital technologies like AI and big data analysis into the business to raise health awareness, prevent development and aggravation of diseases in Vietnam.Under this agreement, Bao Viet Insurance will introduce Hitachi's leading technologies for analyzing medical big data to Bao Viet Direct, an app provided to Bao Viet Insurance policyholders, and will begin providing a new insurance service for improving health, which permits users to easily measure the risk of developing lifestyle-related diseases and receive health guidance. The new service will commence on October 1.In recent years, the growing prevalence of lifestyle-related diseases has been a problem in Vietnam. This growth reflects changes in people's lifestyles, including diet and exercise, which have resulted from the rapid economic growth and expansion o...

ACN Newswire

Mediwelcome Announces 2021 Interim Results

indie 31 8 月

7 minutes

HONG KONG, Aug 31, 2021 - (ACN Newswire via SEAPRWire.com) - The largest provider in the Integrated Healthcare Marketing Solutions Market of cardio-cerebral-vascular diseases (CCVDs), Mediwelcome Healthcare Management & Technology Inc. ("Mediwelcome" or the "Company", together with its subsidiaries, the "Group") is pleased to announce the unaudited consolidated interim results for the six months ended 30 June 2021 (the "Reporting Period" or the "First half of 2021").During the Period, Mediwelcome maintained a positive growth momentum. The Group's total revenue reached approximately RMB339.8 million, representing an increase of approximately 145.0% YoY. Gross profit increased by 27.3% YoY to RMB35.8 million.Revenue by service type For the six months ended 30 June (RMB'000)2021 Proportion 2020 Proportion ChangeMedical conference services 208,510 61.4% 75,087 54.1% 177.7%Patient education and screening services 74,321 21.9% 27,453 19.8% 170.7%Marketing strategy and consulting services 51,046 15.0% 33,151 23.9% 54.0%CRO services 4,092 1.2% 2,920 2.1% 40.1%Internet hospital services 1,827 0.5% 70 0.1% 2,510.0%Total 339,796 100.0% 138,681 100.0% 145.0%Steady Business Growth and Commi...

ACN Newswire

Zhong Ji Longevity Science Announces 2021 Interim Results

indie 31 8 月

9 minutes

HONG KONG, Aug 31, 2021 - (ACN Newswire via SEAPRWire.com) - Zhong Ji Longevity Science Group Limited ("Zhong Ji Longevity Science", together with its subsidiaries, the "Group"; stock code: 0767.HK) is pleased to announce its unaudited interim results for the six months ended 30 June 2021 ("Period under Review").During the Period under Review, the Group has been expediting the development of its longevity science business. In addition to operating and managing it existing businesses of money lending, securities and other investment, financial and investment advisory and property investment, the Group accelerated its business transformation by deploying more resources in its operations through five key divisions, namely, longevity science research, longevity medical testing, longevity biological products, longevity management services and member division. The Group has strived to map out its blueprint in the field of longevity science through a number of mergers and acquisitions as well as establishment of strategic cooperations, and managed to achieve breakthroughs.The Group was principally engaged in the business of money lending, securities and other investments and financial and...

ACN Newswire

EC Healthcare Acquires Veterinary Hospital Chain

indie 16 8 月

4 minutes

HONG KONG, Aug 16, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group enters into a sales and purchase agreement to acquire the entire issued share capital of a veterinary hospital chain (the "Target Companies") and the total consideration will be paid in cash. The Target Companies are principally engaged in provision of veterinary services in Hong Kong and operate five veterinary hospitals with 16 registered veterinary surgeons. According to the unaudited financial information for the year ended 31 March 2021, the profit after tax of the Target Companies amounted to approximately HK$8.3 million.Pursuant to the agreement, the acquisition will be conducted in two tranches. The consideration for the first tranche of the equity interests, namely 51% of the issued share capital, in the veterinary hospital chain is HK$26.2 million. In the final tranche of the acquisition, EC Healthcare will acquire the remaining issued share capital of the veterinary hospital chain. The amount of the c...

ACN Newswire

Sihuan Pharmaceutical(0460.HK): Respond to the special directives to combat illegal medical aesthetics services, Advocate ‘Positive Energy’ of China’s Medical Aesthetics Industry

indie 11 8 月

4 minutes

HONG KONG, Aug 11, 2021 - (ACN Newswire via SEAPRWire.com) - On June 10, 2021, the National Health Commission, leading eight ministries and commissions, issued the "Notice on Distributing the Special Rectification Work Plan for Combating Illegal Medical Aesthetic Services." On August 9, 2021, 'The People's Daily' published an article entitled - 'Medical aesthetic sector needs to achieve best effects and prevent adverse consequences.' The article highlighted the current rectification plan in the medical aesthetic sector is to establish high industry standards, strengthen supervision, and crack down on illegal medical aesthetic services in order to create a clean and reliable medical aesthetic environment. This plan will foster new advances in medical aesthetic industry and encourage the sector's healthy development.The imported product - Letybo (botulinum toxin type A for Injection) is a medical aesthetic product produced by South Korea's Hugel Inc. Bain Capital, a well-known international private equity fund, is the controlling shareholder of Hugel Inc in South Korea. Beijing Meiyan Space Biomedicine Co., Ltd., a subsidiary of Sihuan Pharmaceutical, serves as the product's exclusiv...

ACN Newswire

Following Series A Financing, Scivita Medical Completes Series B Financing of Nearly RMB0.4 Billion to Accelerate the Strategic Layout of Globalization

indie 5 8 月

4 minutes

HONG KONG, Aug 5, 2021 - (ACN Newswire via SEAPRWire.com) - Following the completion of series A round financing, with the acceleration of the research and development and commercialization of endoscopy product, Scivita Medical Technology Co., Ltd. ("Scivita Medical") announced today that it has received nearly RMB0.4 Billion in Series B financing, with new investors such as Hudson Bay Capital Management and Prime Capital, as well as continuous support from existing shareholders such as GL Ventures, Lilly Asia Ventures and Matrix Partners China. This round of financing will continue to be used for research and development, capacity expansion, and domestic and international commercialization of innovative products in endoscopy and related fields.Since its inception, Scivita Medical has taken globalization as an important strategy and has set up R&D centers in Suzhou, China and Tokyo, Japan to promote simultaneous global R&D, patent application, registration and commercialization of its products, and strives to building a global leading platform for innovative products in endoscopy and related fields. The successful completion of this round of financing fully reflects the rec...

ACN Newswire

EC Healthcare and Prenetics Form Strategic Partnership to Pioneer the Future of Medicine

indie 29 7 月

5 minutes

HONG KONG, Jul 29, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group signed a memorandum of understanding with Prenetics Limited ("Prenetics") for a strategic collaboration in relation to the formation of a "Healthnomics collaboration". The partnership will be focused on assembling health data resources from ECH and innovative genetics and diagnostic testing services from Prenetics to create the future of medicine, steering the development in preventive & precision medicine, drug discovery and health policy steering for governments.Under the collaboration, (i) EC Healthcare shall be the designated offline fulfillment partner of Prenetics online business; (ii) EC Healthcare shall be granted the exclusive license to market and sell certain Prenetics DNA testing products under the CircleDNA and Circle Medical brand in the Greater Bay Area; (iii) EC Healthcare shall be the marketing and operational partners to promote Prenetics diagnostic and genetic testing products; and (iv) EC Healthcare an...

ACN Newswire

EC Healthcare Announced Quarterly Sales Volume, Successfully Expanded New Flagship Service Centre

indie 27 7 月

3 minutes

HONG KONG, Jul 27, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that, to fulfill the strong demand for medical and healthcare services, on 26 July 2021, the Group has expanded its flagship service centre at Langham Place Office Tower in Mong Kok, with a newly leased floor with gross floor area of approximately 17,900 square feet. The newly leased floor is for the Group's businesses of aesthetic medical and medical specialist services, including but not limited to the Group's first ophthalmology centre and a new obstetrics and gynaecology centre. After the expansion, the total service area of the Group in Langham Place Office Tower has increased to 9 floors and the aggregate floor area of the clinics and service centres of the Group increased to approximately 431,000 square feet. The Board believes the aforementioned expansion will become a growth driver for the Group's businesses, further consolidate the Group's position in the industry as a one-stop comprehensive healthcare and medical service provider...

SeaPRwire

Medical Companies in Germany Boost Investor Confidence with AsiaPresswire’s Medical Distribution Packages

pandora 10 7 月

4 minutes

Berlin, Germany / SEAPRWire / Medical shares soared as a result of the coronavirus pandemic. Investors will be closely monitoring the tech sector and C-suite Medical executives will be looking to make every effort to boost brand perception. With AsiaPresswire's Medical Distribution Platform, Medical leaders can effectively distribute their company news, updates and performance reports to the GERMANY's most-read Medical media outlets and publications to effectively increase brand awareness. Via AsiaPresswire's GERMANY press release distribution packages, executives and teams of Medical companies can reach millions of potential GERMANY readers by distributing company news on Yahoo Finance, Yahoo News, Bloomberg, BusinessInsider, Associated Press, advFN, MarketWatch, MarketScreener, FT.com, NASDAQ.com as well other popular GERMANY Medical websites available on-demand, such as Morning Star, Reuters, and The Street. "While there is a potential for strong government regulations in GERMANY, looming over the tech sector in the months to come, there is also an opportunity for the firms to boost investor confidence through powerful Medical campaigns," said TY Song, AsiaPresswire's COO of GER...

ACN Newswire

EC Healthcare Further Issue Shares to Strategic Shareholder Dr. Cheng Chi Kong and Aspex Management To Enhance Collaboration in Deploying Medical Real Estate Strategy

indie 9 7 月

5 minutes

HONG KONG, Jul 9, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group's strategic shareholders Dr. Cheng Chi Kong and Aspex Management further increase equity stake in the Group via Top-up Placing, further enhancing the strategic relationship and empowering the Group's development. The Group conditionally agreed to effectively issue and allot 6,455,172 and 10,758,621 new Shares at HK$14.50 per Share to Dr. Cheng Chi Kong, Adrian JP and Aspex Master Fund (the "Purchasers"), respectively, through Top-up Placing. Such shares representing approximately 1.55% of the issued share capital of the Company and approximately 1.53% of its enlarged issued share capital immediately following the Top-up Placing. The Group expects to receive net proceeds of approximately HK$248.8 million from the transaction and intends to use the proceeds for clinic network expansion in Hong Kong and the Greater Bay Area in the PRC, mergers and acquisitions and general corporate purposes. Haitong International Securities Compa...

ACN Newswire

EC Healthcare Announces FY2020/21 Annual Results

indie 30 6 月

8 minutes

HONG KONG, Jun 30, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its annual results for the fiscal year ended 31 March 2021 (the "Year").Business Highlights -- Introduced numerous strategic shareholders including Dr. Cheng Chi Kong, Goldman Sachs Asia, Champion REIT, etc. -- Revenue from medical services surged 54.0% to HK$960 million, with its contributions to total revenue rose to 46.1%-- Revenue in the Mainland China increased by 52.5% to HK$135 million-- Second-half total revenue jumped 61.0% versus first half, second-half profit after tax surged by 223.2% versus first half-- Earnings before interest, taxes, depreciation, and amortization ("EBITDA") amounted to HK$397 million, profit after tax was HK$226 million and basic earnings per share were 18.8 HK cents-- The board of directors (the "Board") proposed final cash dividend of 12.9 HK cents per share, which together with the interim dividend of 3 HK cents per share, will bring the total annual dividend to 15.9 HK cents per share, representing...

ACN Newswire

China Biotech Services (8037.HK): Confident shareholders are taking long on their books in anticipation of promising results to be generated from the double engines of growth on cell therapy and precision diagnostic businesses

indie 28 6 月

7 minutes

HONG KONG, Jun 28, 2021 - (ACN Newswire via SEAPRWire.com) - 2021-6-23 / Gelonghui - The Company's self-developed cell therapy product was approved by NMPA to enter into phase I clinical trial as a class I new drugSource: official website of NMPAWith the recent approval of the first CAR-T cell therapy product for marketing in China, a brand-new era of immune cell therapy has just begun.According to the announcement of National Medical Products Administration of China (NMPA), Axicabtagene Ciloleucel injection (code name: FKC876), a CAR-T cell therapy product of Fosun Kite, was officially approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma (including diffuse large B-cell lymphoma (DLBCL) non-specific type, primary mediastinal B-cell lymphoma (PMBCL), high-grade B-cell lymphoma and DLBCL transformed from follicular lymphoma) after second-line or higher systemic therapy.China Biotech Services took its first show in the field of CAR-T cell R&D through its acquisition of Shanghai Longyao Biotech in July 2018.By now, Shanghai Longyao Biotech has built a first-class scientific and R&D transformation team and has pooled up more than 10 prod...

ACN Newswire

EC Healthcare Acquires Pet Industry Business, Allowing Clientele and Business Synergies, To Consolidate and Corporatize Pet Industry

indie 15 6 月

4 minutes

HONG KONG, Jun 15, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group enters the pet industry and will acquire 51% equity interests in King Equity, Eternal Harvest, HKVIC and Crown Leader (the "Target Companies") from Dr. Tiong and Dr. Tan for a total consideration of HK$66.00 million in cash. The Target Companies are principally engaged in the provision of veterinary services in Hong Kong and operate two veterinary hospitals and two veterinary imaging centres in Hong Kong with 14 registered veterinary surgeons, each Target Company operates a veterinary hospital/veterinary imaging centre. According to the unaudited financial information for the year ended 31 March 2021, the profit after tax and net assets of the Target Companies amounted to HK$21.87 million and HK$30.28 million respectively. Upon completion of the acquisitions, the financial results of the Target Companies will be consolidated into the consolidated financial statements of the Group.Each of Dr. Tiong and Dr. Tan gu...

SeaPRwire

Over 100 people who visited Ion Orchard turn up for Covid-19 testing at Raffles Medical in Shaw Centre

aseanpr 12 6 月

3 minutes

SINGAPORE - More than a 100 people who had visited Ion Orchard in the past two weeks turned up for testing at a medical centre in Scotts Road on Saturday (June 12) morning. Long lines formed outside and inside Shaw Centre as people waited their turn to get swabbed at Raffles Medical Centre from 8.30am. Most of the people in the line said they were getting tested just to be safe. Others, like Madam Aparna, 71, a housewife, said she and her husband wanted to get tested for the safety of the people around them. “We are doing it more for the others,” she said. The couple visited the Daiso outlet in Ion last Tuesday (June 8) for about 30 minutes. Madam Aparna added that they have both been fully vaccinated and feel safe. Ms Margie Ceitom, 39, a maid who was at Shaw Centre with her employer, said she did not have any symptoms, but since she and her employer had visited Ion on May 27, the two of them decided to get tested on her employer’s advice. Another man in the line, who wanted to be known only as Mr Ng, said he could not remember when he visited Ion but had received a message from the TraceTogether app a few days ago. The 51-year-old said: “The message said I may have been possibly ...

ACN Newswire

Strategic Collaboration Memorandum between EC Healthcare and China Medical System Utilizes the Synergy of Upstream and Downstream of the Aesthetic Medical Industry, Promotes the Development of Medical Products and Talents

indie 11 6 月

6 minutes

HONG KONG, Jun 11, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* and China Medical System Holdings Limited (the "CMS", SEHK stock code: 867), jointly announce that the Group and a subsidiary of the CMS entered into a memorandum in relation to the strategiccollaboration, including but not limited to setting up an aesthetic medical marketing centre for distribution and marketing of aesthetics medication and related products initially in Hong Kong , and exploring to set up an aesthetic medical training and education platform for registered practitioners, and further exploring the formation of a nationwide aesthetic medical doctor partnership business platform.The Group is the largest non-hospital medical service provider in Hong Kong based in the Greater Bay Area, providing medical, aesthetic medical and healthcare services. The CMS Group is an innovation-driven specialty pharma with a focus on sales and marketing in China, with more than two decades proven record of experience in successful drug promotion in multi d...

ACN Newswire

Strategic collaboration Memorandum between EC Healthcare and China Medical System Utilize the Synergy of Upstream and Downstream of the Aesthetic Medical Industry, Jointly Promote the Development of Medical Products and Talents

indie 11 6 月

6 minutes

ACN Newswire

Strategic collaboration Memorandum between EC Healthcare and China Medical System

indie 11 6 月

6 minutes

ACN Newswire

Dingdang Health raises US$220 million in new financing round

indie 8 6 月

5 minutes

BEIJING, Jun 8, 2021 - (ACN Newswire via SEAPRWire.com) - China's leading integrated online healthcare platform Dingdang Health announced today that it has raised US$220 million in its latest financing round. This round was led by TPG Capital Asia and co-led by OrbiMed and Redview Capital. Other investors included, Valliance, Travis Global Limited (which is an affiliate of Orchid Asia), Summer Capital, and Yingke PE.Mr. Yang Wenlong, founder and chairman of Dingdang Health, said: "With this round of financing, Dingdang Health will press ahead with its online-to-offline strategy to cover services including medical care, medicine delivery and medical insurance. Riding on the new trend of online medical care and medication services amid Covid-19, we aim at providing all-encompassing online services catering to various needs including consultation, drug purchase, chronic disease management and psychological consultation through product upgrades and technological innovation.""I would like to express my heartfelt gratitude to our existing and new shareholders for their recognition. Investors such as TPG, OrbiMed and Redview Capital have extensive investment experience in the health field...

ACN Newswire

USFDA recognized Antrodia cinnamomea mycelia (NDIN No.1170)

indie 20 5 月

4 minutes

TAIPEI, May 20, 2021 - (ACN Newswire via SEAPRWire.com) - The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back two hundred years ago, while people in the Western world know little about this ingredient. The USFDA NDI acknowledgement without objection to Greenyn's Antromax was the 1st notification after numerous attempts in the past 14 years. We are honored to establish a stepping-stone for the A. cinnamomea to the US health markets estimated at 10 billion US dollars.Dr. Kao Shung-te (middle) of China Medical University Hospital and Dr. Houng Jer-yiing (left) of I-Shou University Medical School presented the study results of the randomized double-blind clinical trial and the bioavailability of Antromax in different dosages forms, respectively.Antromax(R)– dripping pills, mycelia powder, emulsion powder (left to right).Manufacturing site of Greenyn Biotechnology in TaichungHealth food of Antromax(R) in livercare in Taiwan (left) and Antromax(R) complex beverage (right).USFDA acknowledged Antrodia cinnamomea as new dietary ingredientsOn April 12th, Greenyn Biotechnology Corporation hosted a seminar - "The international development of Taiwan's Antrod...

SeaPRwire

Goh Keng Swee Foundation donates $1.85m to needy students on his 11th death anniversary

aseanpr 14 5 月

3 minutes

SINGAPORE - To commemorate the 11th anniversary of former deputy prime minister Goh Keng Swee's passing on Friday (May 14), the foundation set up under his name donated a total of $1.85m to financially disadvantaged students from Singapore's four communities and needy medical students at the National University of Singapore (NUS). The Goh Keng Swee Foundation was set up by his wife, Dr Phua Swee Lian, in 2008 to encourage the values of her late husband. She said: "One of the objectives of the Goh Keng Swee Foundation is to continue in some small way Keng Swee's aspiration to improve the lot of the less privileged and the needy in society. "Throughout his tenure in political office, Keng Swee had a firm conviction that education is the only way to uplift the quality of life for these people." During his 25 years in politics, Dr Goh was instrumental in the development of Singapore. He has held cabinet appointments including deputy prime minister and helmed the finance, defence and education portfolios. In 1981, Dr Goh set up the Government of Investment Corporation, with plans to protect the country's reserves from unprecedented economic crisis. He was also key to numerous national p...

2026 年 4 月
一	二	三	四	五	六	日
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30